Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

265 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Baz M, et al. N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11. N Engl J Med. 2009. PMID: 19907034 No abstract available.
Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
Baz M, Abed Y, Simon P, Hamelin ME, Boivin G. Baz M, et al. J Infect Dis. 2010 Mar;201(5):740-5. doi: 10.1086/650464. J Infect Dis. 2010. PMID: 20100088
Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus.
Papenburg J, Baz M, Hamelin MÈ, Rhéaume C, Carbonneau J, Ouakki M, Rouleau I, De Serres G, Boivin G. Papenburg J, et al. Among authors: baz m. Clin Vaccine Immunol. 2011 Mar;18(3):520-2. doi: 10.1128/CVI.00449-10. Epub 2011 Jan 12. Clin Vaccine Immunol. 2011. PMID: 21228145 Free PMC article.
Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
Baz M, Carbonneau J, Rhéaume C, Cavanagh MH, Boivin G. Baz M, et al. Viruses. 2018 Nov 3;10(11):610. doi: 10.3390/v10110610. Viruses. 2018. PMID: 30400276 Free PMC article.
Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets.
Hamelin ME, Baz M, Bouhy X, Beaulieu E, Dubé K, Mallett C, Boivin G. Hamelin ME, et al. Among authors: baz m. Antivir Ther. 2011;16(5):775-9. doi: 10.3851/IMP1794. Antivir Ther. 2011. PMID: 21817200
Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets.
Hamelin ME, Baz M, Abed Y, Couture C, Joubert P, Beaulieu E, Bellerose N, Plante M, Mallett C, Schumer G, Kobinger GP, Boivin G. Hamelin ME, et al. Among authors: baz m. PLoS Pathog. 2010 Jul 22;6(7):e1001015. doi: 10.1371/journal.ppat.1001015. PLoS Pathog. 2010. PMID: 20661429 Free PMC article.
A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
Abed Y, Baz M, Boivin G. Abed Y, et al. Among authors: baz m. J Infect Dis. 2009 Jan 15;199(2):180-3. doi: 10.1086/595736. J Infect Dis. 2009. PMID: 19046066
Activity of the oral neuraminidase inhibitor A-322278 against the oseltamivir-resistant H274Y (A/H1N1) influenza virus mutant in mice.
Baz M, Abed Y, Nehmé B, Boivin G. Baz M, et al. Antimicrob Agents Chemother. 2009 Feb;53(2):791-3. doi: 10.1128/AAC.01276-08. Epub 2008 Nov 17. Antimicrob Agents Chemother. 2009. PMID: 19015327 Free PMC article.
Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
Abed Y, Nehmé B, Baz M, Boivin G. Abed Y, et al. Among authors: baz m. Antiviral Res. 2008 Feb;77(2):163-6. doi: 10.1016/j.antiviral.2007.08.008. Epub 2007 Sep 10. Antiviral Res. 2008. PMID: 17919743
Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.
Pizzorno A, Abed Y, Plante PL, Carbonneau J, Baz M, Hamelin MÈ, Corbeil J, Boivin G. Pizzorno A, et al. Among authors: baz m. Antimicrob Agents Chemother. 2014 Nov;58(11):6398-405. doi: 10.1128/AAC.02956-14. Epub 2014 Aug 11. Antimicrob Agents Chemother. 2014. PMID: 25114143 Free PMC article.
265 results
Jump to page